Tissue engineering scaffold containing alginate, glycosaminoglycan and collagen and preparation method thereof

A technology of tissue engineering scaffold and alginate, which is applied in medical science, prosthesis, etc., can solve the problems that the size, volume and density cannot be adjusted, the composition ratio is single, and it is difficult to adapt to the growth and reproduction of various tissue and organ cells.

Inactive Publication Date: 2010-01-27
JINAN UNIVERSITY
View PDF0 Cites 20 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] At present, the tissue engineering scaffolds prepared by research at home and abroad generally have a single component distribution ratio, a small application range, poor controllability of degradation and absorption rates, and cannot form a three-dimensional through-hole porous structure in the scaffold, and cannot adjust the pore size accord

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] The tissue engineering scaffold is made of the following raw material components, and the percentages involved are percentages by weight:

[0058] Chitosan: 5%

[0059] Collagen: 30%

[0060] Sodium Alginate: 5%

[0061] Hyaluronic Acid: 0.1%

[0062] Carbodiimide: 0.01%

[0063] Chondroitin Sulfate: 0.1%

[0064] Polyvinyl alcohol: 20%

[0065] The remaining three distilled water;

[0066] And add growth factors and active substances with the following mass concentrations: (mass concentration is the ratio of the quality of the following substances to the volume of the above-mentioned raw material mixture, the same below)

[0067] Cell growth factor: 65ng / ml

[0068] Fibronectin: 70ng / ml

[0069] Laminin: 25ng / ml

[0070] The composition of cell growth factors is: fibroblast growth factor (bFGF) 15ng / ml, epidermal growth factor (EGF) 25ng / ml, transforming growth factor (TGF-β1) 30ng / ml;

[0071] The above-mentioned tissue engineering scaffold is prepared by th...

Embodiment 2

[0079] Chitosan: 15%

[0080] Collagen: 5%

[0081] Sodium Alginate: 10%

[0082] Hyaluronic Acid: 0.1%

[0083] Carbodiimide: 0.01%

[0084] Chondroitin Sulfate: 0.1%

[0085] Polyvinyl alcohol: 20%

[0086] The remaining three distilled water;

Embodiment 3

[0088] The tissue engineering scaffold is made of the following raw material components, and the percentages involved are percentages by weight:

[0089] Chitosan: 30%

[0090] Collagen: 5%

[0091] Sodium Alginate: 25%

[0092] Hyaluronic Acid: 3%

[0093] Carbodiimide: 0.1%

[0094] Chondroitin Sulfate: 0.5%

[0095] Polyvinyl alcohol: 5%

[0096] Cell growth factor: 130ng / ml

[0097] Fibronectin: 60ng / ml

[0098]Laminin: 25ng / ml

[0099] The remainder is triple distilled water.

[0100] The above-mentioned tissue engineering scaffold is prepared by the following steps:

[0101] (1) Take chitosan and collagen according to the above ratio and dissolve them in the acetic acid solution of 4

[0102] (2) Slowly add the fully mixed chitosan and collagen mixed solution into the chondroi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Epidermal growth factoraaaaaaaaaa
Transforming growth factoraaaaaaaaaa
Tensile strengthaaaaaaaaaa
Login to view more

Abstract

The invention belongs to the tissue engineering scaffold field and particularly provides a tissue engineering scaffold containing alginate, glycosaminoglycan and collagen and a preparation method thereof. The tissue engineering scaffold provided by the invention is prepared by the following raw materials by weight percent: 5-30% of chitosan, 5-30% of collagen, 5-30% of alginate, 0.1-3% of hyaluronic acid, 0.01-0.05% of crosslinking agent, 0.1-3% of chondroitin sulfate, 5-20% of polyvinyl alcohol and the balance tertiary distilled water. For optimization, the tissue engineering scaffold also contains a proper amount of cell growth factor, fibronectin and laminin. The tissue engineering scaffold can be processed and shaped and can be used to prepare products with different forms and thickness, the shaping method is easy to operate, the raw materials are easy to get and not expensive and the tissue engineering scaffold can be used for scale industrialized production.

Description

technical field [0001] The invention relates to a tissue engineering scaffold material, in particular to a tissue engineering scaffold containing alginate, glycosaminoglycan and collagen and a preparation method thereof. Background technique [0002] The defect or loss of function of tissues and organs due to accidents, diseases, genetics, and aging is the primary problem affecting human life and quality of life. When a tissue or organ in a certain part of the human body is traumatized, the clinically available treatment methods are autologous transplantation, allogeneic transplantation or xenotransplantation. However, these methods have shortcomings such as insufficient donors, immune rejection, and high surgical costs. A large number of patients died due to the lack of suitable donors and effective organ replacements, and were not treated. Therefore, how to realize the repair and regeneration of damaged tissues and organs, and how to realize the recovery of their functio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61L27/26A61L27/54A61L27/56A61L27/58A61L27/24A61L27/22A61L27/20A61L27/16
Inventor 李沁华
Owner JINAN UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products